Ole A. Holtermann - Concepedia

Author

Ole A. Holtermann

Roswell Park Comprehensive Cancer Center

Also Known As

O A Holtermann, O Holtermann, O. A. HOLTERMANN, O. A. Holtermann, O. Holtermann, O.A. Holtermann, OLE A. HOLTERMANN, Ole A. Holtermann

Publications

636

Citations

H-Index

Concepts

All Affiliations

Roswell Park Comprehensive Cancer Center Statens Serum Institut University at Buffalo, State University of New York University of Notre Dame National Experimental University of the Armed Forces

About

Ole A. Holtermann is an author at Roswell Park Comprehensive Cancer Center specializing in medicine, immunology, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	15	431
2	Allergy	2	2	43
3	Cell Biology	2	2	64
4	Biology	1	1	19
5	Cellular Physiology	1	1	13

Ole A. Holtermann

Publications

488

Citations

H-Index

Page 1

	Year	Citations
Treatment of kaposi's sarcoma with vinblastine Edmund Klein, Robert A. Schwartz, Yona Laor, Cancer Surgical OncologyMedicineFourteen PatientsVinblastine SulfatePathology	1980	80
Selective cytotoxicity of peritoneal leucocytes for neoplastic cells Ole A. Holtermann, Edmund Klein, George P. Casale Cellular Immunology GranulocyteImmunologyCell DeathSelective CytotoxicityMedicine	1973	70
Preliminary observations on tumor regressions induced by local administration of a lymphoid cell culture supernatant fraction in patients with cutaneous metastatic lesions Ben W. Papermaster, Ole A. Holtermann, Edmund Klein, Clinical Immunology and Immunopathology Local AdministrationLymphoid NeoplasiaPreliminary ObservationsMedicineCutaneous Metastatic Lesions	1976	44
Lymphokine properties of a lymphoid cultured cell supernatant fraction active in promoting tumor regression Ben W. Papermaster, Ole A. Holtermann, Edmund Klein, Clinical Immunology and Immunopathology Tumor RegressionLymphoid NeoplasiaCell Supernatant FractionImmunologyLymphokine Properties	1976	36
Mycosis fungoides associated with florid sarcoid reactions Robert A. Schwartz, Gordon H. Burgess, Ole A. Holtermann, Journal of Surgical Oncology	1980	30
In Vitro Destruction of Tumor Cells by Human Monocyte Ole A. Holtermann, I. Djerassi, Barbara Lisafeld, Experimental Biology and Medicine Human CellHuman Blood MonocytesMalignant DiseaseImmunologyVitro Destruction	1974	28
AN APPARENT HISTOINCOMPATIBILITY BETWEEN MICE CHRONICALLY INFECTED WITH LYMPHOCYTIC CHORIOMENINGITIS VIRUS AND THEIR UNINFECTED SYNGENEIC COUNTERPARTS Ole A. Holtermann, Jeannine A. Majde Transplantation HistocompatibilityClinical ImmunologyLaboratory ImmunologyImmunologyViral Pathogenesis	1971	27
The Development of Soluble (S) And Viral (V) Antigens of Influenza A Virus In Tissue Culture As Studied By The Fluorescent Antibody Technique Ole A. Holtermann, W. Daniel Hillis, Margaret A. J. Moffat Acta Pathologica Microbiologica Scandinavica VaccinationViral DiagnosticsImmunologyVirologyFluorescent Antibody Technique	1960	26
Reduced Interferon Response in Mice Congenitally Infected with Lymphocytic Choriomeningitis Virus Ole A. Holtermann, Edward A. Havell Journal of General Virology ImmunologyViral PathogenesisPathologyMice Congenitally InfectedViral Persistence	1970	19
cis-Dichlorodiammineplatinum(II) and DTIC in malignant melanoma. Karakousis Cp, Gétaz Ep, Sigurður Björnsson, PubMed UrologyMalignant DiseaseMedicineMelanomaPharmacology	1980	19

Page 1